| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 64635 |
|
2,640 |
1,542 |
$628K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,612 |
3,724 |
$399K |
| 64636 |
|
2,561 |
1,488 |
$394K |
| 64625 |
|
279 |
231 |
$131K |
| 64483 |
|
627 |
450 |
$109K |
| 64633 |
|
263 |
187 |
$75K |
| 77003 |
|
1,091 |
671 |
$59K |
| 64634 |
|
215 |
154 |
$56K |
| 64493 |
|
510 |
262 |
$55K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
408 |
363 |
$53K |
| 99205 |
Prolong outpt/office vis |
303 |
239 |
$50K |
| 27096 |
|
488 |
319 |
$39K |
| 99152 |
|
1,893 |
889 |
$32K |
| 64451 |
|
94 |
43 |
$24K |
| 64494 |
|
476 |
220 |
$23K |
| 77002 |
|
387 |
261 |
$20K |
| 20610 |
|
340 |
249 |
$15K |
| 64495 |
|
226 |
92 |
$10K |
| 76942 |
|
114 |
85 |
$7K |
| 20552 |
|
372 |
237 |
$7K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
565 |
353 |
$6K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
5,012 |
2,777 |
$4K |
| 64445 |
|
71 |
50 |
$4K |
| 64479 |
|
17 |
13 |
$3K |
| 95886 |
|
14 |
12 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,866 |
1,901 |
$2K |
| 64484 |
|
26 |
12 |
$2K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,181 |
775 |
$416.78 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,986 |
942 |
$306.02 |